DrugMapper
Browse
Therapeutic Area
CANCER (51)
CARDIOVASCULAR (45)
DENTISTRY (2)
DERMATOLOGY (31)
DIABETES DRUGS & ENDOCRINOLOGY (61)
EMERGENCY MEDICINE (3)
ENT (5)
EYE (23)
GASTROINTESTINAL (29)
HEMATOLOGY (23)
MUSCULOSKELETAL (28)
NEUROLOGY DRUGS & NERVOUS SYSTEM (50)
PEDIATRICS (27)
PHARMACOLOGY (8)
PREGNANCY AND GYNECOLOGY (30)
RESPIRATORY (42)
RHEUMATOLOGY (19)
OTHER (1482)
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Primary Target
Target Level
Level 1
Level 2
Level 3
Level 4
Level 5
Level 6
Active Pharmaceutical Ingredients (APIs)
Small Molecules
ProDrugs
Antibodies
CNS drugs
Metabolites
Search
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Target Sequence
Chemical Structure
Physicochemical Properties
Analyze
Networks
Chemical Similarity
Scaffold Similarity
KNIME workflow
Downloads
Web services
Bulk Downloads
About
DrugMapper FAQs
Data Sources
Contact Us
Display Options:
Drug type
Therapeutic Area
Route of administration
Mechanism of Action
Indication
Status
Total:
10647
GS-9901
1
Small molecule
Investigational
Unknown
Unknown
Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma, Follicular
Unknown
GS-9901
×
Maximum Phase:
1
First Approval:
None
UNII:
U09Q76B8VK
Molecule Type:
Small molecule
Molecular Formula:
C22H17ClFN9O
Molecular Weight:
477.89
AlogP:
2.96
PSA:
161.42
HBD:
3.0
HBA:
#RotB:
5.0
Source:
LGX-806
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Serine/threonine-protein kinase B-raf inhibitor
LGX-806
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
2-DEOXY-D-GLUCOSE
1
Small molecule
Investigational
Unknown
Unknown
Prostatic Neoplasms, Castration-Resistant
Unknown
2-DEOXY-D-GLUCOSE
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
C6H12O5
Molecular Weight:
164.16
AlogP:
-2.19
PSA:
90.15
HBD:
4.0
HBA:
#RotB:
1.0
Source:
TRIS(8-HYDROXYQUINOLINATO)GALLIUM
1
Unknown
Investigational
Unknown
Unknown
Neoplasms
Unknown
TRIS(8-HYDROXYQUINOLINATO)GALLIUM
×
Maximum Phase:
1
First Approval:
None
UNII:
R3G3HB38O4
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
LEISH-F3
1
Unknown
Investigational
Unknown
Unknown
Leishmaniasis; Leishmaniasis, Visceral
Unknown
LEISH-F3
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
RG-7594
1
Antibody
Investigational
Unknown
Unknown
Unknown
Unknown
RG-7594
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
RGI-7000
1
Small molecule
Investigational
Unknown
Unknown
Hepatitis B, Chronic; Hepatitis C, Chronic; Lung Neoplasms; Multiple Myeloma
Unknown
RGI-7000
×
Maximum Phase:
1
First Approval:
None
UNII:
WX671898JF
Molecule Type:
Small molecule
Molecular Formula:
C50H99NO9
Molecular Weight:
858.34
AlogP:
10.48
PSA:
168.94
HBD:
7.0
HBA:
#RotB:
44.0
Source:
CALANOLIDE A
1
Small molecule
Investigational
Unknown
Unknown
HIV Infections
Unknown
CALANOLIDE A
×
Maximum Phase:
1
First Approval:
None
UNII:
S5A9TQN46W
Molecule Type:
Small molecule
Molecular Formula:
C22H26O5
Molecular Weight:
370.45
AlogP:
4.38
PSA:
68.9
HBD:
1.0
HBA:
#RotB:
2.0
Source:
4G7XH22
1
Antibody
Investigational
Unknown
Unknown
Leukemia; Lymphoma
Unknown
4G7XH22
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
AMG-427
1
Unknown
Investigational
Unknown
Unknown
Leukemia, Myeloid, Acute
Unknown
AMG-427
×
Maximum Phase:
1
First Approval:
None
UNII:
P9I9Z3MF7Z
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
INZOMELID
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
INZOMELID
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
C19H24N4O3S
Molecular Weight:
388.49
AlogP:
2.95
PSA:
93.09
HBD:
2.0
HBA:
#RotB:
4.0
Source:
PIVAGABINE
1
Small molecule
Investigational
Unknown
Unknown
Anxiety; Depressive Disorder
Unknown
PIVAGABINE
×
Maximum Phase:
1
First Approval:
None
UNII:
C53SV0WO4V
Molecule Type:
Small molecule
Molecular Formula:
C9H17NO3
Molecular Weight:
187.24
AlogP:
1.01
PSA:
66.4
HBD:
2.0
HBA:
#RotB:
4.0
Source:
AB-101
1
Unknown
Investigational
Unknown
Unknown
Lymphoma, Non-Hodgkin
Unknown
AB-101
×
Maximum Phase:
1
First Approval:
None
UNII:
EH13UJP078
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
MLN-591RL
1
Antibody
Investigational
Unknown
Unknown
Unknown
Unknown
MLN-591RL
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
LINZAGOLIX
1
Small molecule
Investigational
Unknown
Unknown
Kidney Diseases; Liver Diseases; Endometriosis
Gonadotropin-releasing hormone receptor antagonist
LINZAGOLIX
×
Maximum Phase:
1
First Approval:
None
UNII:
7CDW97HUEX
Molecule Type:
Small molecule
Molecular Formula:
C22H15F3N2O7S
Molecular Weight:
508.43
AlogP:
3.45
PSA:
119.85
HBD:
2.0
HBA:
#RotB:
7.0
Source:
TEGLARINAD
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
TEGLARINAD
×
Maximum Phase:
1
First Approval:
None
UNII:
NUG9P5GWZB
Molecule Type:
Small molecule
Molecular Formula:
C30H43ClN5O8+
Molecular Weight:
637.15
AlogP:
3.91
PSA:
145.77
HBD:
2.0
HBA:
#RotB:
23.0
Source:
AZD-4769
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Epidermal growth factor receptor erbB1 inhibitor
AZD-4769
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
C28H27NO3S
Molecular Weight:
457.6
AlogP:
6.7
PSA:
59.42
HBD:
1.0
HBA:
#RotB:
11.0
Source:
NP031112
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
NP031112
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
GSK-2018682
1
Small molecule
Investigational
Unknown
Unknown
Multiple Sclerosis; Multiple Sclerosis, Relapsing-Remitting
Unknown
GSK-2018682
×
Maximum Phase:
1
First Approval:
None
UNII:
NJL503AIJA
Molecule Type:
Small molecule
Molecular Formula:
C22H21ClN4O4
Molecular Weight:
440.89
AlogP:
5.06
PSA:
103.27
HBD:
1.0
HBA:
#RotB:
8.0
Source:
ENADENOTUCIREV
1
Unknown
Investigational
Unknown
Unknown
Ovarian Neoplasms; Rectal Neoplasms
Unknown
ENADENOTUCIREV
×
Maximum Phase:
1
First Approval:
None
UNII:
KX7ZYR6OQW
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ON123300
1
Small molecule
Investigational
Unknown
Unknown
Neoplasms
Unknown
ON123300
×
Maximum Phase:
1
First Approval:
None
UNII:
QJ8RO3296G
Molecule Type:
Small molecule
Molecular Formula:
C24H27N7O
Molecular Weight:
429.53
AlogP:
3.27
PSA:
90.08
HBD:
1.0
HBA:
#RotB:
4.0
Source:
IOFOLASTAT
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
IOFOLASTAT
×
Maximum Phase:
1
First Approval:
None
UNII:
9T6EBU5ER1
Molecule Type:
Small molecule
Molecular Formula:
C19H26IN3O7
Molecular Weight:
535.34
AlogP:
1.62
PSA:
165.06
HBD:
6.0
HBA:
#RotB:
14.0
Source:
CPI-1205
1
Small molecule
Investigational
Unknown
Unknown
Lymphoma, Follicular; Neoplasms; Prostatic Neoplasms, Castration-Resistant
Unknown
CPI-1205
×
Maximum Phase:
1
First Approval:
None
UNII:
455J2479FY
Molecule Type:
Small molecule
Molecular Formula:
C27H33F3N4O3
Molecular Weight:
518.58
AlogP:
4.72
PSA:
79.36
HBD:
2.0
HBA:
#RotB:
7.0
Source:
ABT 737
1
Small molecule
Investigational
Unknown
Unknown
Breast Neoplasms
Unknown
ABT 737
×
Maximum Phase:
1
First Approval:
None
UNII:
Z5NFR173NV
Molecule Type:
Small molecule
Molecular Formula:
C42H45ClN6O5S2
Molecular Weight:
813.45
AlogP:
7.88
PSA:
128.13
HBD:
2.0
HBA:
#RotB:
16.0
Source:
MK-6186
1
Small molecule
Investigational
Unknown
Unknown
HIV Infections
Unknown
MK-6186
×
Maximum Phase:
1
First Approval:
None
UNII:
K3978U665M
Molecule Type:
Small molecule
Molecular Formula:
C21H12Cl2N6O
Molecular Weight:
435.27
AlogP:
5.33
PSA:
92.41
HBD:
1.0
HBA:
#RotB:
4.0
Source:
MK-2748
1
Small molecule
Investigational
Unknown
Unknown
Hepatitis C
Unknown
MK-2748
×
Maximum Phase:
1
First Approval:
None
UNII:
7YM030A71C
Molecule Type:
Small molecule
Molecular Formula:
C42H56N6O10S
Molecular Weight:
837.01
AlogP:
3.84
PSA:
204.33
HBD:
3.0
HBA:
#RotB:
8.0
Source:
LBS-008
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
LBS-008
×
Maximum Phase:
1
First Approval:
None
UNII:
63WI9S8P1M
Molecule Type:
Small molecule
Molecular Formula:
C21H21F5N4O2
Molecular Weight:
456.42
AlogP:
3.63
PSA:
69.3
HBD:
1.0
HBA:
#RotB:
2.0
Source:
CG200745
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
CG200745
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
AVE-9633
1
Antibody
Investigational
Unknown
Unknown
Leukemia, Myeloid
Myeloid cell surface antigen CD33 binding agent
AVE-9633
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
BMS-698769
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Hepatocyte growth factor receptor inhibitor
BMS-698769
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
DOTAMTATE PB-212
1
Unknown
Investigational
Unknown
Unknown
Neuroendocrine Tumors
Unknown
DOTAMTATE PB-212
×
Maximum Phase:
1
First Approval:
None
UNII:
E9N7QV53AK
Molecule Type:
Unknown
Molecular Formula:
C65H91N17O16PbS2
Molecular Weight:
1642.67
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
SNS-314
1
Small molecule
Investigational
Unknown
Unknown
Neoplasms
Serine/threonine-protein kinase Aurora inhibitor
SNS-314
×
Maximum Phase:
1
First Approval:
None
UNII:
802IFJ0Z8X
Molecule Type:
Small molecule
Molecular Formula:
C18H15ClN6OS2
Molecular Weight:
430.95
AlogP:
4.52
PSA:
95.06
HBD:
3.0
HBA:
#RotB:
5.0
Source:
OCTANOIC ACID
1
Small molecule
Investigational
Unknown
Unknown
Carcinoma, Non-Small-Cell Lung; Cholangiocarcinoma; Essential Tremor; Gallbladder Neoplasms; Leukemia, Myeloid, Acute; Small Cell Lung Carcinoma; Myelodysplastic Syndromes; Sarcoma, Myeloid
Unknown
OCTANOIC ACID
×
Maximum Phase:
1
First Approval:
None
UNII:
OBL58JN025
Molecule Type:
Small molecule
Molecular Formula:
C8H16O2
Molecular Weight:
144.21
AlogP:
2.43
PSA:
37.3
HBD:
1.0
HBA:
#RotB:
6.0
Source:
MK-0752
1
Small molecule
Investigational
Unknown
Unknown
Central Nervous System Neoplasms; Neoplasms
Unknown
MK-0752
×
Maximum Phase:
1
First Approval:
None
UNII:
9JD9B4S53T
Molecule Type:
Small molecule
Molecular Formula:
C21H21ClF2O4S
Molecular Weight:
442.91
AlogP:
5.34
PSA:
71.44
HBD:
1.0
HBA:
#RotB:
6.0
Source:
KB-004
1
Antibody
Investigational
Unknown
Unknown
Glioblastoma; Myelodysplastic Syndromes; Primary Myelofibrosis
Ephrin type-A receptor 3 inhibitor
KB-004
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
1
2
…
107
108
109
110
111
112
113
…
304
305
Next »
Download Option
Close
Header
Compound Name
Maximum Phase
Compound Structure
Smile
Inchi
InchiKey
Compound Properties
Molecular Formula
Molecular Weight
ALogP
PSA